Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study

@graham74GC This is a very small study out of China, so some caveats apply, but an impressive ORR and CR given the difficulty of the population. Don’t love the WBRT in non responders though. https://t.co/UYZ8UXPU1D

Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study #lymphoma #lymsm https://t.co/b6zn5YKkVJ

Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study #lymphoma #lymsm https://t.co/Af4WvXMceK